Aureus Pharma Licenses AurSCOPE® GPCR to Serono
News Apr 12, 2006
Aureus Pharma has announced that Serono has become a customer of its AurSCOPE GPCR knowledge database.
In this multi-year agreement, scientists at Serono Pharmaceutical Research Institute in Geneva will have access to both the AurSCOPE knowledge database and AurQUEST, a web application designed to query Aureus’ knowledge bases.
AurSCOPE GPCR is comprised of detailed biological activity quantitative data from patents and journals form.
G-Protein Coupled Receptors are a major interest for the pharmaceutical industry as they are targets in a number of therapeutic areas including CNS, cardiovascular, metabolic disease, obesity, oncology and others.
"Aureus Pharma’s knowledgebase on GPCR will provide Serono researcher’s with high quality quantitative data which will complement our in-house experimental platform," commented Serono’s Dr. Serge Halazy, Head of Research, Switzerland.
"We are very pleased to have Serono join our growing list of customers in the pharmaceutical and biotechnology industry," said Dr. Andre Michel, CEO of Aureus Pharma.
"Having access to the high quality data in AurSCOPE GCPR will aid researchers in the discovery of new GPCR targeted drugs."
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
WuXi Biologics to Invest in Biologics Manufacturing Facility in SingaporeNews
WuXi Biologics' first overseas site in Asia.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018